Cook Steven L. sold $149K of OMDA

Cook Steven L. (Chief Financial Officer) sold 6,800 shares of Omada Health, Inc. (OMDA) at an average of $21.86 ($21.80–$22.52, $0.15M total) across 2 trades on 2026-09-10 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Cook Steven L.
Published Sep 14, 2026, 9:12 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 14, 2026, 9:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$OMDA
Bearish
medium confidence
Mentioned
$OMDA
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OMDABearishLow
01

Why it matters

The CFO's sale is modest and unlikely to move the stock significantly, but it adds to the flow of insider activity data.

02

Market read

Routine insider sale with limited trading relevance.

03

What to watch

The CFO's 10b5‑1 plan may have been pre‑scheduled, reducing informational value.

Relevance 3/10Novelty 4/10Timing: post‑market 2026‑09‑10

Background

Form 4 filing discloses insider transactions required by SEC regulations.

Company-level read

Ticker impact

$OMDABearishMedium confidence
Context

CFO Steven L. Cook sold 6,800 shares for $148,639.90 on 2026-09-10 via a 10b5‑1 plan.

Expected impact

Potential modest downward pressure on OMDA price.

Evidence & confidence

The sale size is small relative to holdings, but CFO insider sales often weigh on market perception.

Market effects

Minimal impact on digital health sector.

No regional effect beyond OMDA.

Limited to investors tracking insider activity.

Counterpoint

The sale could be routine liquidity planning, not a negative signal.

Key entities

  • Omada Health, Inc.

    Digital health platform listed on Nasdaq under OMDA.

  • Steven L. Cook

    Chief Financial Officer of Omada Health.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$OMDAHigh

Omada Health Earnings Call Signals Strong Growth Ahead

Omada Health (OMDA) reported Q3 revenue of $91M, up 34% YoY, with GAAP net income of $7M vs. a loss last year. Adjusted EBITDA rose to $12M. Management raised 2026 revenue guidance to $344M-$346M and adjusted EBITDA to $32M-$34M, citing strong demand for diabetes and hypertension programs. The company expects Q4 seasonality and GLP-1 coverage uncertainty.

$OMDAMed

What Omada Health (OMDA) Said on Its Q3 Earnings Call

Omada Health (OMDA) expects Q4 revenue to decline due to seasonal factors, with adjusted EBITDA also moderating. The company ended Q3 with $243M in cash and no debt. CEO Sean Duffy will transition to executive chair in 2027, with Shao taking over as CEO. Omada's GLP-1 Care Track showed a 6% average weight loss at 12 weeks, according to peer-reviewed research.

$OMDAMedAI 8/10

Omada Health Inc (OMDA) (Q3 2026) Earnings Call Highlights: Record Revenue, Membership

Omada Health Inc (OMDA) reported record revenue and membership growth in Q3 2026. However, new enrollments are expected to decline in Q4 due to seasonality and tough comparisons. GLP-1 market dynamics and rising healthcare costs create uncertainty for 2027. Adjusted EBITDA is expected to moderate due to increased R&D and staffing. The company aims for 20%+ growth in 2027 through expanding covered lives, improving enrollment rates, and increasing engagement.